drugset / Trial / NCT00044005
Safety and Tolerability Study of Drug to Treat Schizophrenia
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the long-term safety of SM-13496 in patients with schizophrenia.
Timeline
- Start
- 2002-09
- Primary completion
- 2003-11
- Completion
- 2003-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lurasidone | Small molecule | 20 mg | Oral |
| Subject | Lurasidone | Small molecule | 40 mg | Oral |
| Subject | Lurasidone | Small molecule | 80 mg | Oral |